Diabetes drug ‘staves off weight gain’ after smoking cessation
But the GLP-1 receptor had no effect on smoking abstinence rates or cravings, found the Swiss trial.
Dulaglutide could help motivate patients to quit smoking and avoid early relapse, say Swiss doctors who found the drug counteracts “expected” post-cessation weight gain.
Their randomised controlled trial demonstrated that adults who received a 12-week course of the GLP-1 receptor agonist in addition to standard care lost 1kg on average after quitting.
